Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary resistant to EGFR-TKIs such as gefitinib. Curcumin has been k...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Exp Clin Cancer Res
Main Authors: Chen, Ping, Huang, Han-Peng, Wang, Yi, Jin, Jun, Long, Wei-Guo, Chen, Kan, Zhao, Xiao-Hui, Chen, Chen-Guo, Li, Jian
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567416/
https://ncbi.nlm.nih.gov/pubmed/31196210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1234-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker